Skip to main content Skip to search Skip to main navigation

PIC/S: Revised Recommendations on Qualification and Validation

PIC/S has published a fundamentally revised version of its “Recommendations on Qualification and Validation” (PI 006-4). The new document was issued on 30 July 2026, will enter into force on 1 October 2026, and replaces the 2007 edition. The revised document has been expanded from 26 to 49 pages.

The revised recommendations consistently apply a lifecycle and risk-based approach to qualification and validation. They include expanded guidance on quality risk management, data governance and data integrity, change control, performance qualification and ongoing process verification.

The chapters on process validation and cleaning validation have also been extensively updated. PIC/S states that the number of validation batches should be scientifically justified using a risk-based approach and explicitly describes the reference in Annex 15 PIC/S / EU GMP Guide to three consecutive validation batches as a transitional provision. The cleaning validation chapter now provides additional recommendations on HBELs, worst-case selection, manual cleaning and ongoing cleaning verification.

Although PI 006-4 is a recommendation rather than a legally binding GMP requirement, it clearly reflects the current expectations of PIC/S inspectorates. Several topics go beyond the current Annex 15 and may indicate the direction of its ongoing revision.

Our GMP expert Dr. Sabine Paris has analyzed the most important changes for you and compiled them in a PDF.

Request it for free now


Source:

PIC/S: Recommendations on Qualification and Validation PI 006-4

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

News: EMA

EMA Clarifies Batch Numbering for Parallel-Traded Medicines

EMA updated its GMP/GDP Q&A collection by revising the answer to Question 4 concerning Chapter 5 of the EU GMP Guide. It explains which batch numbers should appear on the packaging of parallel-traded medicines.

Read more
Question of the Week | GMP-Verlag

Why is it Important to use Consistent Microbiological Air Monitoring Methods in Pharmaceutical Cleanrooms?

Here's the answer:
Read more
Cleaning Validation: When PDE Reports and the Worst-Case Selection do not Align

Cleaning Validation: When PDE Reports and the Worst-Case Selection do not Align

Robust PDE reports form the basis of risk-based cleaning validation. This article highlights common deficiencies identified during GMP inspections and explains how they can be avoided.

Read more
News: Europe

EDQM: New Working Party on 3D-printed Medicinal Products

The European Pharmacopoeia Commission (EPC) approved the creation of a working party on 3D-printed medicinal products. Its aim is to support the development of appropriate quality standards in the European Pharmacopoeia (Ph. Eur.).
Read more
EMA: 14 New Nitrosamines for Appendix 1

EMA: 14 New Nitrosamines for Appendix 1

Appendix 1 of EMA’s Questions and Answers on nitrosamine impurities has been updated. This appendix contains acceptable intakes (AIs) established for N-nitrosamines.
Read more
WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO published a revised draft of its “WHO guidelines on quality risk management”. Working document QAS/26.994 is open for public comment until 15 November 2026.
Read more
Previous
Next